Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Postoperative Nausea, Vomiting and Pain After Bariatric Surgery - a National Registry Study (BAROSPOR)

27. august 2026 oppdatert av: Jakob Walldén, Umeå University

Pain and Nausea in the Post-Anaesthesia Care Unit After Bariatric Surgery: A Registry Study Linking the Swedish Perioperative Register (SPOR) and the Scandinavian Obesity Surgery Registry (SOReg)

Around 4,000-5,000 bariatric (weight-loss) operations are performed in Sweden every year. Nausea, vomiting and pain are common immediately after these operations, cause considerable suffering and increase the intensity and length of hospital care. Bariatric surgery is one of the procedures with the highest risk of postoperative nausea and vomiting (PONV): about one third of patients experience PONV already in the recovery unit, and registry data indicate that around 40% report severe pain at the same stage.

This study links two national quality registries - the Swedish Perioperative Register (SPOR) and the Scandinavian Obesity Surgery Registry (SOReg) - to describe how often adult patients experience nausea, vomiting and pain in the post-anaesthesia care unit after primary bariatric surgery, and to identify patient, anaesthetic and surgical factors associated with these outcomes. The study tests whether total intravenous anaesthesia, the addition of a regional nerve block, and preoperative health-related quality of life are associated with PONV and pain, and whether early PONV or pain is associated with complications, unplanned hospital care or reoperation up to one year after surgery. The results are intended to show how well current evidence on preventing PONV and pain is applied in everyday practice and where care can be improved.

Studieoversikt

Detaljert beskrivelse

BACKGROUND Bariatric surgery is common in Sweden with 4,000-5,000 procedures per year. Data on each operation are recorded in the Swedish Perioperative Register (SPOR), covering more than 90% of all surgical procedures in Sweden with automatic data transfer from hospital IT systems, and in the Scandinavian Obesity Surgery Registry (SOReg), with a coverage of approximately 98% of bariatric surgery. Postoperative nausea and vomiting (PONV) and pain are frequent after bariatric surgery. Evidence-based guidelines exist, but 25-40% of surgical patients still experience PONV, and up to 50% may experience severe postoperative pain. Risk factors are validated at a general level but not specifically for bariatric surgery.

OBJECTIVES

  1. To describe the risk of early PONV and pain in the post-anaesthesia care unit (PACU) after primary bariatric surgery.
  2. To identify factors associated with early PONV and pain.
  3. To test the hypotheses that total intravenous anaesthesia (compared with inhalational anaesthesia) and the addition of a regional block are associated with lower risk of PONV or pain in the PACU; that poorer preoperative health-related quality of life (RAND-36) is associated with higher risk of PONV, pain and severe pain; and that PONV or pain in the PACU is associated with higher risk of postoperative complications up to one year after surgery. Separate hypothesis tests are performed for PONV and pain.

DESIGN Exploratory observational cohort study based on registry data. Patients aged 18 years or older with a primary bariatric procedure registered in SOReg during 2018-2027 are identified. Records are linked to SPOR by Uppsala Clinical Research Center (UCR) using personal identity number and date of surgery (+/- 3 days). If several SPOR records fall within the interval, each is included as a separate row with an index variable linking to the SOReg operation. Each individual is assigned a unique serial number and the dataset delivered to the research group contains pseudonymised data only. Data extractions are made at most once per year from 2025; the first analyses cover 2018-2023.

VARIABLES From SOReg: preoperative data (patient characteristics, comorbidity, laboratory values, preoperative work-up, RAND-36), operative data (procedure type, technique, intraoperative complications) and postoperative follow-up up to one year (complications, hospital care, reoperation). From SPOR: patient characteristics, process data, operative data (diagnosis, procedure, anaesthesia type, times, deviations), postoperative data (pain, nausea/vomiting, deviations, level of care) and date of death.

STATISTICAL ANALYSIS Descriptive statistics with univariable and multivariable analysis of associations. Candidate variables include sex, age, comorbidity, preoperative pain, anaesthesia type, procedure type, surgical technique and length of stay. The expected sample is approximately 70% of all bariatric operations in Sweden, about 3,000 patients per year; the main reason for exclusion is expected to be missing PACU registration of pain and/or nausea at some hospitals. As the study includes more than half of the target population, no formal power calculation is performed.

DATA PROTECTION Only pseudonymised data are handled. Data are stored at Umeå University with access restricted to the study researchers, in accordance with current legislation.

Studietype

Observasjonsmessig

Registrering (Antatt)

30000

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Sundsvall, Sverige, 851 86
        • Rekruttering
        • Sundsvall Hospital, Department of Anaesthesia and Intensive Care
      • Umeå, Sverige, 901 87
        • Rekruttering
        • Umeå University, Department of Diagnostics and Intervention
        • Underetterforsker:
          • Antonio Moraitis, MD
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jakob Walldén, MD, PhD
        • Underetterforsker:
          • Magnus Hultin, MD, PhD
        • Underetterforsker:
          • Yucel Cengiz, MD, PhD

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

All adult patients registered in the Scandinavian Obesity Surgery Registry (SOReg) with a primary bariatric procedure during 2018-2027 and a matching operation record in the Swedish Perioperative Register (SPOR).

Beskrivelse

Inclusion Criteria:

  • Age 18 years or older
  • Primary bariatric surgery registered in SOReg during 2018-2027

Exclusion Criteria:

  • Revision bariatric surgery
  • If more than one bariatric operation is registered for the same patient, only the primary operation is included

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Adults undergoing primary bariatric surgery in Sweden 2018-2027
Patients aged 18 years or older with a primary bariatric procedure registered in the Scandinavian Obesity Surgery Registry (SOReg) 2018-2027 and a matching operation record in the Swedish Perioperative Register (SPOR).

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Incidence of postoperative nausea and/or vomiting in the post-anaesthesia care unit
Tidsramme: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
Number of operations with registered nausea and/or vomiting in the PACU divided by the total number of operations. Source: SPOR variable "Illamående postoperativt" (postoperative nausea).
During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
Pain intensity in the post-anaesthesia care unit, numerical rating scale (NRS) 0-10
Tidsramme: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
Median NRS score (0 = no pain, 10 = worst imaginable pain). Source: SPOR variables "Smärta inom 1 tim efter ankomst UVA" (pain within 1 hour of PACU arrival) and "Smärta postoperativt, högsta" (highest postoperative pain).
During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
Incidence of severe pain in the post-anaesthesia care unit
Tidsramme: During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)
Number of operations with NRS >= 7 divided by the total number of operations.
During the stay in the post-anaesthesia care unit (approximately 0-4 hours after surgery)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Proportion of patients with postoperative complications, unplanned hospital care or reoperation - 6 weeks
Tidsramme: Up to 6 weeks after surgery
Complications (including Clavien-Dindo grade), unplanned hospital care and reoperation as registered in SOReg at the 6-week follow-up.
Up to 6 weeks after surgery
Proportion of patients with postoperative complications, unplanned hospital care or reoperation - 1 year
Tidsramme: Up to 1 year after surgery
Complications (including Clavien-Dindo grade), unplanned hospital care and reoperation as registered in SOReg at the 1-year follow-up.
Up to 1 year after surgery

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Jakob Walldén, MD, PhD, Umeå University

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. oktober 2025

Primær fullføring (Antatt)

31. desember 2027

Studiet fullført (Antatt)

1. desember 2028

Datoer for studieregistrering

Først innsendt

27. august 2026

Først innsendt som oppfylte QC-kriteriene

27. august 2026

Først lagt ut (Faktiske)

1. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

27. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere